Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 1
2019 1
2020 1
2021 5
2022 2
2023 2
2024 5
2025 5
2026 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

20 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean trabulsi asaad (17 results)?
Predictors and timing of venous thromboembolism and overall survival in lymphoma.
Trabolsi A, Plate TE, Lavorgna T, Kronenfeld RS, Campoverde LE, Morgenstern-Kaplan D, Mercadel A, Caballero M, Zhao W, Moskowitz C, Lossos IS, Soff GA. Trabolsi A, et al. Leuk Lymphoma. 2026 May;67(6):1376-1384. doi: 10.1080/10428194.2026.2644580. Epub 2026 Mar 20. Leuk Lymphoma. 2026. PMID: 41860758
Impact of extranodal involvement at CAR T-cell therapy on outcomes in patients with relapsed or refractory large B-cell lymphoma-Results from a multicenter cohort study.
St-Pierre F, Bhatta S, Doukas PG, Jenkin M, Annunzio K, Rojek AE, Gibson A, Tiger YK, McCall B, Alhamad K, Hansen A, Alderuccio JP, Adewale O, Patel K, Trabolsi A, Lossos IS, Fitzgerald L, Ollila TA, Matasar MJ, Kline J, Karmali R, Epperla N. St-Pierre F, et al. Among authors: trabolsi a. Blood Cancer J. 2025 Jun 21;15(1):110. doi: 10.1038/s41408-025-01318-5. Blood Cancer J. 2025. PMID: 40544154 Free PMC article.
Outcomes of follicular lymphoma with leukemic phase in the modern era: results from a large multicenter study.
Trabolsi A, Han S, Epperla N, Annunzio K, Baidoun F, Alhaj Moustafa M, Morgenstern-Kaplan D, Doukas P, St-Pierre F, McCall B, Fitzgerald L, Sandoval-Sus J, Dalal S, Reis IM, Chapman-Fredricks JR, Kim SH, Au C, Otto NB, Alhamad K, Ollila T, Karmali R, Shouse G, Lossos IS, Alderuccio JP. Trabolsi A, et al. Blood Neoplasia. 2024 Dec 28;2(1):100063. doi: 10.1016/j.bneo.2024.100063. eCollection 2025 Feb. Blood Neoplasia. 2024. PMID: 40454403 Free PMC article.
Loncastuximab tesirine with rituximab in patients with relapsed or refractory follicular lymphoma: a single-centre, single-arm, phase 2 trial.
Alderuccio JP, Alencar AJ, Schatz JH, Kuker RA, Pongas G, Reis IM, Lekakis LJ, Spiegel JY, Sandoval-Sus J, Beitinjaneh A, Stanchina MD, Trabolsi A, Lossos IS, Rosenblatt JD, Lessen DS, Moskowitz CH. Alderuccio JP, et al. Among authors: trabolsi a. Lancet Haematol. 2025 Jan;12(1):e23-e34. doi: 10.1016/S2352-3026(24)00345-4. Epub 2024 Dec 7. Lancet Haematol. 2025. PMID: 39662486 Clinical Trial.
Genomic, immunologic, and prognostic associations of TROP2 (TACSTD2) expression in solid tumors.
Morgenstern-Kaplan D, Kareff SA, Trabolsi A, Rodriguez E, Krause H, Ribeiro JR, Tan H, Antonarakis ES, Lou E, Nagasaka M, Algaze S, Lenz HJ, Liu SV, Halmos B, Hoon DSB, Seeber A, Ma PC, El-Deiry WS, Vanderwalde AM, Lopes G. Morgenstern-Kaplan D, et al. Among authors: trabolsi a. Oncologist. 2024 Nov 4;29(11):e1480-e1491. doi: 10.1093/oncolo/oyae168. Oncologist. 2024. PMID: 38986529 Free PMC article.
The Genomic, Transcriptomic, and Immunologic Landscape of HRAS Mutations in Solid Tumors.
Kareff SA, Trabolsi A, Krause HB, Samec T, Elliott A, Rodriguez E, Olazagasti C, Watson DC, Bustos MA, Hoon DSB, Graff SL, Antonarakis ES, Goel S, Sledge G, Lopes G. Kareff SA, et al. Among authors: trabolsi a. Cancers (Basel). 2024 Apr 19;16(8):1572. doi: 10.3390/cancers16081572. Cancers (Basel). 2024. PMID: 38672653 Free PMC article.
20 results